Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13826 | 747 | 31.0 | 52% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2417 | 3681 | OVOTOXICITY//TIME TO PREGNANCY//ANTINEOPLASTIC DRUGS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANTINEOPLASTIC DRUGS | Author keyword | 19 | 32% | 7% | 50 |
2 | TOXICITY ENVIRONMENTAL | Author keyword | 6 | 53% | 1% | 8 |
3 | HAZARDOUS DRUGS | Author keyword | 4 | 56% | 1% | 5 |
4 | CYTOSTATIC DRUGS | Author keyword | 3 | 20% | 2% | 15 |
5 | SAFE HANDLING | Author keyword | 3 | 50% | 1% | 4 |
6 | SAFE HANDLING PRACTICES | Author keyword | 3 | 60% | 0% | 3 |
7 | HOSPITAL MEDICATION SYSTEM | Author keyword | 2 | 67% | 0% | 2 |
8 | PROGRAM CHEM EXPOSURE ASSESSMENT | Address | 2 | 67% | 0% | 2 |
9 | SALMONELLA TYPHIMURIUM YG1024 | Author keyword | 2 | 67% | 0% | 2 |
10 | URINARY MUTAGENICITY | Author keyword | 2 | 29% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTINEOPLASTIC DRUGS | 19 | 32% | 7% | 50 | Search ANTINEOPLASTIC+DRUGS | Search ANTINEOPLASTIC+DRUGS |
2 | TOXICITY ENVIRONMENTAL | 6 | 53% | 1% | 8 | Search TOXICITY++ENVIRONMENTAL | Search TOXICITY++ENVIRONMENTAL |
3 | HAZARDOUS DRUGS | 4 | 56% | 1% | 5 | Search HAZARDOUS+DRUGS | Search HAZARDOUS+DRUGS |
4 | CYTOSTATIC DRUGS | 3 | 20% | 2% | 15 | Search CYTOSTATIC+DRUGS | Search CYTOSTATIC+DRUGS |
5 | SAFE HANDLING | 3 | 50% | 1% | 4 | Search SAFE+HANDLING | Search SAFE+HANDLING |
6 | SAFE HANDLING PRACTICES | 3 | 60% | 0% | 3 | Search SAFE+HANDLING+PRACTICES | Search SAFE+HANDLING+PRACTICES |
7 | HOSPITAL MEDICATION SYSTEM | 2 | 67% | 0% | 2 | Search HOSPITAL+MEDICATION+SYSTEM | Search HOSPITAL+MEDICATION+SYSTEM |
8 | SALMONELLA TYPHIMURIUM YG1024 | 2 | 67% | 0% | 2 | Search SALMONELLA+TYPHIMURIUM+YG1024 | Search SALMONELLA+TYPHIMURIUM+YG1024 |
9 | URINARY MUTAGENICITY | 2 | 29% | 1% | 6 | Search URINARY+MUTAGENICITY | Search URINARY+MUTAGENICITY |
10 | ANTINEOPLASTIC DRUG | 2 | 19% | 1% | 9 | Search ANTINEOPLASTIC+DRUG | Search ANTINEOPLASTIC+DRUG |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOSTATIC DRUGS | 111 | 67% | 13% | 100 |
2 | PHARMACY PERSONNEL | 73 | 96% | 3% | 23 |
3 | SURFACE CONTAMINATION | 44 | 57% | 7% | 52 |
4 | PHARMACY TECHNICIANS | 38 | 84% | 3% | 21 |
5 | HANDLING ANTINEOPLASTIC DRUGS | 29 | 55% | 5% | 36 |
6 | POLYVINYL CHLORIDE GLOVES | 28 | 81% | 2% | 17 |
7 | PHARMACEUTICAL PLANT WORKERS | 26 | 100% | 1% | 11 |
8 | HANDLING CYTOSTATIC DRUGS | 25 | 77% | 2% | 17 |
9 | HOSPITAL PHARMACY | 22 | 62% | 3% | 23 |
10 | URINARY CYCLOPHOSPHAMIDE EXCRETION | 21 | 90% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods | 2003 | 60 | 134 | 71% |
Monitoring occupational exposure to cancer chemotherapy drugs | 1996 | 41 | 94 | 86% |
Biomarkers of occupational exposure do anticancer agents: A minireview | 2011 | 14 | 90 | 56% |
Drugs hazardous to healthcare workers - Evaluation of methods for monitoring occupational exposure to cytostatic drugs | 1999 | 49 | 75 | 91% |
Analysis of anticancer drugs: A review | 2011 | 63 | 446 | 9% |
Regulations and Recommendations for Appropriate Disposal of Antineoplastics | 2010 | 0 | 1 | 100% |
Exposure risk in the handling and administration of chemotherapy agents: A review and synthesis of the literature | 2000 | 3 | 19 | 95% |
Oncolor is ten years old: the age of discretion for the Lorraine network in oncology | 2004 | 1 | 4 | 75% |
The genotoxic risk in health care workers occupationally exposed to cytotoxic drugsA comprehensive evaluation by the SCE assay | 2009 | 6 | 96 | 39% |
Handling chemotherapy drugsDo medical gloves really protect? | 2015 | 0 | 23 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM CHEM EXPOSURE ASSESSMENT | 2 | 67% | 0.3% | 2 |
2 | PUBL MED SOCIAL SAFETY | 1 | 38% | 0.4% | 3 |
3 | CYTOGENET IMMUNOL | 1 | 50% | 0.3% | 2 |
4 | EXPT MED OCCUPAT MED | 1 | 50% | 0.3% | 2 |
5 | PHARMACOKINET CORE | 1 | 100% | 0.3% | 2 |
6 | STATUTORY ACCID INSURANCE PREVENT HLTH W | 1 | 50% | 0.3% | 2 |
7 | ENVIRONM HYG IND TOXICOL | 1 | 20% | 0.8% | 6 |
8 | ENVIRONM TOXICOL TESTING | 1 | 19% | 0.8% | 6 |
9 | HYG IND TOXICOL SECT | 1 | 40% | 0.3% | 2 |
10 | PREVENT OCCUPAT MED PUBL HLTH | 1 | 40% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000125357 | RUBBER INDUSTRY//RUBBER WORKERS//RUBBER MANUFACTURING |
2 | 0.0000095279 | UMU TEST//SOS CHROMOTEST//COMPARISON ON MUTAGENICITY |
3 | 0.0000088090 | ARJUNOLIC ACID//CALCIUM GLUCARATE//D SACCHARIC ACID 1 |
4 | 0.0000079752 | ORAL CHEMOTHERAPY//ORAL ANTICANCER AGENTS//ORAL ANTICANCER DRUGS |
5 | 0.0000073646 | FEMALE VETERINARIANS//VETERINARIANS//VETERINARY PRACTICE |
6 | 0.0000068857 | 1 HYDROXYPYRENE//BITUMEN FUMES//URINARY 1 HYDROXYPYRENE |
7 | 0.0000063375 | SISTER CHROMATID EXCHANGE//SISTER CHROMATID EXCHANGES//HIGH FREQUENCY CELL |
8 | 0.0000058291 | MICRONUCLEI//MICRONUCLEUS//BUCCAL MUCOSA CELLS |
9 | 0.0000047443 | OPERATING ROOM PERSONNEL//ANESTHETIC GASES//OPERATING ROOMS CONTAMINATION |
10 | 0.0000045308 | 7 HYDROXYMETHOTREXATE//GLUCARPIDASE//HIGH DOSE METHOTREXATE |